Antinociceptive effects of opioids following acute and chronic administration of butorphanol: influence of stimulus intensity and relative efficacy at the mu receptor

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Psychopharmacology

• Publication date

  1999-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s002130050945PMID 10353428
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The mu opioid irreversible antagonist beta-funaltrexamine differentiates the discriminative stimulus effects of opioids with high and low efficacy at the mu opioid receptor.

  1998cited by this paper
• Cross-Tolerance to Etorphine Differentiates μ-Opioid Agonists in a Rat Tail Withdrawal Assay

  1998cited by this paper
• The µ opioid irreversible antagonist beta-funaltrexamine differentiates the discriminative stimulus effects of opioids with high and low efficacy at the μ opioid receptor

  1998cited by this paper
• Tolerance and cross-tolerance to the rate-suppressing effects of opioids in butorphanol-treated rats: influence of maintenance dose and relative efficacy at the mu receptor

  1998cited by this paper
• Discriminative stimulus effects of the mixed-opioid agonist/antagonist dezocine: cross-substitution by mu and delta opioid agonists.

  1997cited by this paper
• Butorphanol-mediated antinociception in mice: partial agonist effects and mu receptor involvement.

  1997cited by this paper
• Down-regulation of mu-opioid receptor by full but not partial agonists is independent of G protein coupling.

  1997cited by this paper
• Antagonistic modulation between the delta opioid agonist BW373U86 and the mu opioid agonist fentanyl in mice.

  1997cited by this paper
• Contribution of individual differences to discriminative stimulus, antinociceptive and rate‐decreasing effects of opioids: importance of the drug's relative intrinsic efficacy at the mu receptor

  1996cited by this paper
• Opioids and rate of positively reinforced behavior: II. Antagonism by β-funaltrexamine.

  1996cited by this paper
• Behavioral tolerance and cross‐tolerance to the response rate‐decreasing effects of mu opioids in rats

  1996cited by this paper
• Butorphanol: characterization of agonist and antagonist effects in rhesus monkeys.

  1995cited by this paper
• Rat strain differences in the potentiation of morphine-induced analgesia by stress.

  1995cited by this paper
• Opioid antinociception in a rat model of visceral pain: systemic versus local drug administration.

  1995cited by this paper
• Epidural morphine combined with epidural or intravenous butorphanol for postoperative analgesia in pediatric patients.

  1994cited by this paper
• Sensitization and tolerance to the discriminative stimulus effects of mu-opioid agonists

  1994cited by this paper
• Agonist and antagonist effects of mixed action opioids in the pigeon drug discrimination procedure: influence of training dose, intrinsic efficacy and interanimal differences.

  1993cited by this paper
• Opioid thermal antinociception in rhesus monkeys: receptor mechanisms and temperature dependency.

  1993cited by this paper
• Development of tolerance to the analgesic activity of mu agonists after continuous infusion of morphine, meperidine or fentanyl in rats.

  1992cited by this paper
• Pharmacokinetics of butorphanol tartrate in rabbits.

  1992cited by this paper
• Discriminative stimulus effects of morphine: effects of training dose on agonist and antagonist effects of mu opioids.

  1992cited by this paper
• Pentazocine-induced biphasic analgesia in mice.

  1991cited by this paper
• Tolerance to morphine-like stimulus effects of mu opioid agonists.

  1991cited by this paper
• Epidural Morphine With Butorphanol for Postoperative Analgesia After Cesarean Delivery

  1991cited by this paper
• Butorphanol's efficacy at mu and kappa opioid receptors: inferences based on the schedule-controlled behavior of nontolerant and morphine-tolerant rats and on the responding of rats under a drug discrimination procedure.

  1990cited by this paper
• Discriminative stimulus effects of opioid agonists in morphine-dependent pigeons.

  1990cited by this paper
• Differential cross-tolerance to opioids in squirrel monkeys responding under a shock titration schedule.

  1990cited by this paper
• Butorphanol, levallorphan, nalbuphine and nalorphine as antagonists in the squirrel monkey.

  1990cited by this paper
• Differential cross-tolerance between intrathecal morphine and sufentanil in the rat.

  1990cited by this paper
• Assessment of relative intrinsic activity of mu-opioid analgesics in vivo by using beta-funaltrexamine.

  1990cited by this paper
• Factors affecting restraint stress-induced potentiation of morphine analgesia.

  1990cited by this paper
• Current and Future Trends in Acute Pain Management

  1989cited by this paper
• Comparative pharmacological and biochemical studies between butorphanol and morphine.

  1989cited by this paper
• Butorphanol precipitates abstinence in morphine dependent rats.

  1989cited by this paper
• Potency of infused spinal antinociceptive agents is inversely related to magnitude of tolerance after continuous infusion.

  1989cited by this paper
• Chronic opioid antagonist treatment: assessment of receptor upregulation.

  1989cited by this paper
• Effects of levorphanol and several kappa-selective opioids on respiration and behavior in rhesus monkeys.

  1988cited by this paper
• Butorphanol Improves CO2 Response and Ventilation after Fentanyl Anesthesia

  1987cited by this paper
• Chronic use of opioid analgesics in non‐malignant pain: Report of 38 cases

  1986cited by this paper
• Restraint stress enhances morphine-induced analgesia in the rat without changing apparent affinity of receptor.

  1985cited by this paper
• Demonstration of non-opioid sigma binding with (d)3H-SKF 10047 in guinea pig brain.

  1985cited by this paper
• Substitution and primary dependence studies in animals.

  1985cited by this paper
• Manual of Pharmacologic Calculations: With Computer Programs

  1984cited by this paper
• Classification of narcotics on the basis of their reinforcing, discriminative, and antagonist effects in rhesus monkeys.

  1982cited by this paper
• Naltrexone-induced opiate receptor supersensitivity.

  1982cited by this paper
• Morphine- and methadone-tolerant mice differ in cross-tolerance to other opiates

  1982cited by this paper
• A simple, reliable method for predicting the physical dependence liability of narcotic antagonist analgesics in the rat.

  1981cited by this paper

• Dosing protocols to increase the efficacy of butorphanol in dogs.

  2022cites this paper
• TRV130 partial agonism and capacity to induce anti‐nociceptive tolerance revealed through reducing available μ‐opioid receptor number

  2021cites this paper
• Antinociceptive effects of mixtures of mu opioid receptor agonists and cannabinoid receptor agonists in rats: Impact of drug and fixed‐dose ratio

  2018cites this paper
• The effects of amphetamine, butorphanol, and their combination on cocaine self-administration.

  2014cites this paper
• Effects of environmental enrichment on sensitivity to mu, kappa, and mixed-action opioids in female rats.

  2008cites this paper
• Activities of mixed NOP and μ‐opioid receptor ligands

  2008cites this paper
• Interactions between opioid agonists and glutamate receptor antagonists

  2008cites this paper
• Acute withdrawal syndrome in a butorphanol-treated patient : an adverse combination of opioids

  2008cites this paper
• Acute withdrawal syndrome in a butorphanol-treated patient: an adverse combination of opioids.

  2008cites this paper
• Low efficacy opioids: implications for sex differences in opioid antinociception.

  2006cites this paper
• Chronic exercise decreases sensitivity to mu opioids in female rats: correlation with exercise output.

  2006cites this paper
• Nociceptive Sensitivity and Opioid Antinociception and Antihyperalgesia in Freund's Adjuvant-Induced Arthritic Male and Female Rats

  2005cites this paper
• Social and environmental influences on opioid sensitivity in rats: importance of an opioid’s relative efficacy at the mu-receptor

  2005cites this paper
• Interactions between opioids and cocaine on locomotor activity in rats: influence of an opioid's relative efficacy at the mu receptor

  2003cites this paper
• Sensitivity to the effects of opioids in rats with free access to exercise wheels: µ-opioid tolerance and physical dependence

  2003cites this paper
• Sex differences in (−)-pentazocine antinociception: Comparison to morphine and spiradoline in four rat strains using a thermal nociceptive assay

  2003cites this paper
• Sex differences in ( – )-pentazocine antinociception: Comparison to morphine and spiradoline in four rat strains using a thermal nociceptive assay

  2003cites this paper
• Sex and rat strain determine sensitivity to κ opioid-induced antinociception

  2002cites this paper
• Age-related differences in sensitivity to the antinociceptive effects of kappa opioids in adult male rats

  2002cites this paper
• Sex and rat strain determine sensitivity to kappa opioid-induced antinociception.

  2002cites this paper
• Pain intolerance in opioid-maintained former opiate addicts: effect of long-acting maintenance agent.

  2001cites this paper
• Importance of sex and relative efficacy at the µ opioid receptor in the development of tolerance and cross-tolerance to the antinociceptive effects of opioids

  2001cites this paper
• Age-related differences in sensitivity to the antinociceptive effects of opioids in male rats

  2001cites this paper
• Endogenous opiates: 1999.

  2000cites this paper
• Sex-related differences in the antinociceptive effects of opioids: importance of rat genotype, nociceptive stimulus intensity, and efficacy at the µ opioid receptor

  2000influential citation
• Attenuation of m -Opioid Tolerance and Cross-Tolerance by the Competitive N -Methyl- D -aspartate Receptor Antagonist LY235959 Is Related to Tolerance and Cross-Tolerance Magnitude 1

  2000cites this paper
• Attenuation of μ-Opioid Tolerance and Cross-Tolerance by the Competitive N-Methyl-d-aspartate Receptor Antagonist LY235959 Is Related to Tolerance and Cross-Tolerance Magnitude

  2000cites this paper